Provided By GlobeNewswire
Last update: Mar 20, 2025
Deal positions STREAMWAY® Systems with an established market leader to drive accelerating growth
Transaction allows Predictive Oncology to be highly focused on its core AI-driven drug discovery capabilities and integrate seamlessly with Renovaro Biosciences
Read more at globenewswire.comNASDAQ:POAI (8/12/2025, 8:11:25 PM)
0.7399
+0.01 (+1.97%)
Find more stocks in the Stock Screener